Physician profile
Joseph Rosado
NPI 1104068584
$1,322.85
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $179 · 2021: $33.10 · 2022: $81.39 · 2023: $117 · 2024: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $264.76 | 2023-2024 | Spravato |
| Alexion Pharmaceuticals, INC. | $165.08 | 2019 | |
| Greenwich Biosciences, INC. | $119.82 | 2019-2020 | |
| Zyla Life Sciences, INC. | $102.05 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $92.84 | 2019-2020 | |
| Genzyme Corporation | $89.26 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $59.95 | 2019-2020 | |
| Si-Bone, INC. | $36.36 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.12 | 2019-2020 | |
| Abbvie INC. | $36.11 | 2021-2022 | |
| Nevro Corp. | $29.11 | 2019 | |
| Tanabe Pharma America, INC. | $28.69 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $24.02 | 2019 | |
| Abbott Laboratories | $23.69 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $20.47 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $18.70 | 2019 | |
| Ironshore Pharmaceuticals INC. | $18.10 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.03 | 2022 | |
| Csl Behring | $17.29 | 2024 | Kcentra |
| Ucb, INC. | $17.06 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.72 | 2020 | |
| Glaxosmithkline, LLC. | $14.50 | 2022 | |
| Avion Pharmaceuticals | $14.14 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.61 | 2022 | |
| Promius Pharma LLC | $13.19 | 2019 | |
| Lilly USA, LLC | $12.38 | 2019 | |
| Boston Scientific Corporation | $11.64 | 2019 | |
| Merz North America, INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rosado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.